Ascletis Pharmaceuticals Co., Ltd.

This study looked at the long-term safety of a daily pill called ASC40 (Denifanstat) for people with moderate to severe acne. About 240 participants who finished a previous 12-week study took the drug for up to 40 weeks. Researchers monitored side effects, blood tests, and skin i…

This early-stage trial tested a new oral drug called ASC61 in 18 adults with advanced solid tumors that had stopped responding to standard treatments or had no standard options. The goal was to check the drug's safety, find the right dose, and see if it could shrink tumors. ASC61…